TokenPost·
NervGen Pharma’s Net Loss Rises 36% to C$6.4 Million

C$6.4M
quarterly net loss
Research and development expenses rose 84% to C$7.9 million, while general and administrative expenses increased 154% to C$3.3 million.
Every crypto headline. One feed. Updated every minute.

Research and development expenses rose 84% to C$7.9 million, while general and administrative expenses increased 154% to C$3.3 million.